This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Novo Nordisk Healthcare Ag. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Biography of Inventor Sanjeev Forsyth
Introduction: Sanjeev Forsyth is an accomplished inventor based in Milton, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hemoglobinopathies.
Latest Patents: Forsyth holds a patent for a compound known as (S)-1-(5-((2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-7-yl)sulfonyl)-3,4,5,6-tetrahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)-3-hydroxy-2-phenylpropan-1-one. This compound is useful for increasing the affinity of hemoglobin for oxygen and includes methods and compositions for treating hemoglobinopathies.
Career Highlights: Forsyth is currently associated with Novo Nordisk Healthcare AG, where he continues to innovate and develop new pharmaceutical solutions. His work has been instrumental in advancing treatments for blood disorders.
Collaborations: Throughout his career, Forsyth has collaborated with notable professionals in the field, including Anna M Ericsson and Neal Green. These partnerships have enhanced the scope and impact of his research.
Conclusion: Sanjeev Forsyth's contributions to the field of medicine through his innovative patents and collaborations highlight his dedication
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile